Planet Briefing

First published · Last updated

PNPLA3-I148M is a neomorph that interferes with two primary hepatic triglyceride clearance pathways

A peer-reviewed article published by Elsevier on 2025-10-01 reports that the PNPLA3 I148M variant functions as a neomorphic protein that disrupts two main liver triglyceride clearance pathways. The source provided is the article title, publisher, and publication date without further experimental details.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence
5/10
Geographic reach
1/10
Global importance
3/10
Impact magnitude
2/10
Positivity
3/10
Urgency
2/10

Why it matters

The result pertains to mechanisms of hepatic triglyceride metabolism and is relevant to related biomedical research.

Sources

Report an issue